The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

By H. Lithell, L. Hansson, Ingmar Skoog, D. Elmfeldt, Albert Hofman, B. Olofsson, P. Trenkwalder, A. Zanchetti. Journal of Hypertension, 2003

1,445 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/72530ca520ba67e5c4e5544b69d39c3824cad4f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2013 ESH/ESC Guidelines for the management of arterial hypertension (2007, background): “RCTs that have shown beneficial effects of antihypertensive treatment in the elderly have used different classes of compounds and so there is evidence in favour of diuretics [287,449,454,470,471], beta-blockers [453,454], calcium antagonists [451,452,460], ACE inhibitors [460], and angiotensin recep”
ESH / ESC Guidelines for the management of arterial hypertension (2013, methodology): “RCTs that have shown beneficial effects of antihypertensive treatment in the elderly have used different classes of compounds and so there is evidence in favour of diuretics,(287,449,454,470,471) betablockers,(453,454) calcium antagonists,(451,452,460) ACE inhibitors,(460) and angiotensin receptor b”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “RCTs that have shown beneficial effects of antihypertensive treatment in the elderly have used different classes of compounds and so there is evidence in favour of diuretics [287,449,454,470,471], beta-blockers [453,454], calcium antagonists [451,452,460], ACE inhibitors [460], and angiotensin recep”
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018, neutral): “, 2003 (290) 12714861 Aim: Incident dementia (cognitive decline as 2o outcome)”
2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, positive): “463,464 467 Although a follow-up study of the Systolic Hypertension in Europe (Syst-Eur) trial showed a relative risk reduction for dementia of 54% with long-term BP-lowering treatment, 211 this was not replicated in the SPRINT MIND trial, which reported that intensive BP-lowering treat-ment…”